Proposed to modulate gene expression in immune tissues and extend lifespan in murine models.
Reference facts
- Also known as
- KE, Lys-Glu
- Category
- Khavinson Bioregulators
- Mechanism of action
- Proposed to modulate gene expression in immune tissues and extend lifespan in murine models.
- Targets
- Thymic gene expression (proposed)
- Indications under research or approved
- Russian gerontology research
- Regulatory status (reference entry)
- Not FDA-approved
- Half-life
- Minutes
- Sequence
- KE
- Sequence notes
- Dipeptide developed by Khavinson group as a thymic immunomodulator bioregulator.
- Molecular weight (Da)
- 275
- First reported
- 1995
Primary References
Explore research articles about Vilon
This is an educational reference, not medical advice. Research findings do not establish safety or efficacy for self-administration. Consult the primary sources for study populations, limitations, and current regulatory status.